Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q114431814
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010638.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q114431814
|
035
|
|
|
‡a
(OCoLC)Q114431814
|
100
|
0 |
|
‡a
Estela Rodriguez-Del Rio
‡c
researcher
‡9
en
|
670
|
|
|
‡a
Author's A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection
|
670
|
|
|
‡a
Author's A novel therapy for melanoma developed in mice: transformation of melanoma into dendritic cells with Listeria monocytogenes.
|
670
|
|
|
‡a
Author's Phagosomes induced by cytokines function as anti-Listeria vaccines: novel role for functional compartmentalization of STAT-1 protein and cathepsin-D
|
919
|
|
|
‡a
phagosomesinducedbycytokinesfunctionasantilisteriavaccinesnovelroleforfunctionalcompartmentalizationofstat1proteinandcathepsin500
‡A
Phagosomes induced by cytokines function as anti-Listeria vaccines: novel role for functional compartmentalization of STAT-1 protein and cathepsin-D
‡9
1
|
919
|
|
|
‡a
goldglyconanoparticlecarryingalisteriolysinopeptideandformulatedwithadvaxtmdeltainulinadjuvantinducesrobusttcellprotectionagainstlisteriainfection
‡A
A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection
‡9
1
|
919
|
|
|
‡a
noveltherapyformelanomadevelopedinmicetransformationofmelanomaintodendriticcellswithlisteriamonocytogenes
‡A
A novel therapy for melanoma developed in mice: transformation of melanoma into dendritic cells with Listeria monocytogenes.
‡9
1
|
996
|
|
|
‡2
SUDOC|072250437
|
996
|
|
|
‡2
BLBNB|001044977
|
996
|
|
|
‡2
ISNI|0000000070989345
|
996
|
|
|
‡2
RERO|A003748078
|
996
|
|
|
‡2
PTBNP|144296
|
996
|
|
|
‡2
NUKAT|n 97039566
|
996
|
|
|
‡2
NTA|184931452
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|